Prediction of Clinical Outcome in Axillary Block

February 13, 2023 updated by: Ji Hee Hong, Keimyung University Dongsan Medical Center

Perfusion Index Value in Predicting the Clinical Outcome of Axillary Block

The primary endpoint of this study was to identify that Perfusion index (PI) has any predictive value for the treatment outcome of cervical radiculopathy

Study Overview

Status

Recruiting

Conditions

Detailed Description

The interscalene brachial plexus block is an effective intervention for reducing postoperative pain but is related to side effects, Suprascapular nerve block and a block of the axillary nerve have been introduced as alternatives to the interscalene brachial plexus for the control of postoperative pain. Previous study demonstrated new method of axillary block using interfascial plane injection guided by ultrasoud. Axillary block has been used widely for the relief of postoperative arm pain.

Recent study deomonstrated good pain relief when ultrasound guided fascial plane injection was performed in patients with cervical radiuculopathy.

The perfusion index (PI) is a numerical value for the ratio between pulsatile and non-pulsatile blood flow measured by a special pulse oximeter. Although the special probe for PI measurement is relatively more expensive compared with ordinary pulse oximetery probes, its benefit as a marker of peripheral perfusion and as an idex for sympathetic stimulation have increased its use progressively. PI has been used widely for the prediction of success of brachial plexus block or axillary block. Changes of PI ratio value showed an excellent predictive value for the success of block.

There have been no studies demonstrating any predictive value of PI in axillary block for the relief of cervical radiulopathy

Study Type

Observational

Enrollment (Anticipated)

70

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Patients who visit the pain clinic

Description

Inclusion Criteria:

  • Cervical foraminal stenosis
  • Cervical central stenosis
  • Cervical disc herniation
  • Cervical spondylolisthesis

Exclusion Criteria:

  • Infection
  • pregnancy
  • allergy to local anesthetic agents
  • previous cervical spine surgery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Perfusion index changes among 4 time periods
Time Frame: baseline, 10 minutes, 20 minutes, 30 minutes after axillary block
Perfusion index changes among 4 time periods
baseline, 10 minutes, 20 minutes, 30 minutes after axillary block
Number of patients showing numerical rating scale reduction more than 50%
Time Frame: 1 month after axillary block
Number of patients showing numerical rating scale reduction more than 50%
1 month after axillary block
Number of patients showing numerical rating scale reduction less than 50%
Time Frame: 1 month after axillary block
Number of patients showing numerical rating scale reduction less than 50%
1 month after axillary block
Number of patients showing no reduction in numerical rating scale
Time Frame: 1 month after axillary block
Number of patients showing no reduction in numerical rating scale
1 month after axillary block
Neck disability index changes between 2 time periods
Time Frame: baseline, 1 month after axillary block
Neck disability index changes between 2 time periods
baseline, 1 month after axillary block

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 13, 2023

Primary Completion (Anticipated)

November 30, 2023

Study Completion (Anticipated)

November 30, 2023

Study Registration Dates

First Submitted

February 3, 2023

First Submitted That Met QC Criteria

February 3, 2023

First Posted (Actual)

February 10, 2023

Study Record Updates

Last Update Posted (Actual)

February 15, 2023

Last Update Submitted That Met QC Criteria

February 13, 2023

Last Verified

February 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe